• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

ASH

Press release: New study demonstrates significant difference between iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled, randomized clinical investigation
December 7, 2018
Pharmaceutical News

Iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled trial

Results of a study comparing the incidence of hypophosphatemia after high dose IV iron substitution have been presented at the 60th annual meeting of the American Society of Hematology. The HOMe aFers trial recruited women with gynaecological bleeding and subsequent iron deficiency. All subjects

More
Press release: New study demonstrates significant difference between iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled, randomized clinical investigation
Pharmaceutical News

Iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled trial

December 7, 2018

Results of a study comparing the incidence of hypophosphatemia after high dose IV iron substitution have been presented at the

More
  • Can You Sue Your Doctor for Blindness Caused by Elmiron?
  • Experts advise European SME packaging firms to expand or seek acquisition prior to Pharmapack Europe
  • FIP advances sustainable health systems by providing new guidance for self-managing reflux symptoms
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector
  • Modernizing Therapeutic Cell Production

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop